Rezolute Inc (RZLT)
4.41
-0.03
(-0.68%)
USD |
NASDAQ |
Dec 24, 16:00
Rezolute Cash from Investing (Quarterly): -49.41M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Janux Therapeutics Inc | 12.67M |
| Cytokinetics Inc | -45.05M |
| TransMedics Group Inc | -47.76M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -16.01M |
| Cash from Financing (Quarterly) | 5.50M |
| Free Cash Flow | -62.80M |
| Free Cash Flow Per Share (Quarterly) | -0.2296 |
| Free Cash Flow Yield | -25.41% |